Literature DB >> 17686471

VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2.

Tiana A Garrett1, Jaap D Van Buul, Keith Burridge.   

Abstract

Vascular endothelial growth factor (VEGF) signaling is critical for both normal and disease-associated vascular development. Dysregulated VEGF signaling has been implicated in ischemic stroke, tumor angiogenesis, and many other vascular diseases. VEGF signals through several effectors, including the Rho family of small GTPases. As a member of this family, Rac1 promotes VEGF-induced endothelial cell migration by stimulating the formation of lamellipodia and membrane ruffles. To form these membrane protrusions, Rac1 is activated by guanine nucleotide exchange factors (GEFs) that catalyze the exchange of GDP for GTP. The goal of this study was to identify the GEF responsible for activating Rac1 in response to VEGF stimulation. We have found that VEGF stimulates biphasic activation of Rac1 and for these studies we focused on the peak of activation that occurs at 30 min. Inhibition of VEGFR-2 signaling blocks VEGF-induced Rac1 activation. Using a Rac1 nucleotide-free mutant (G15ARac1), which has a high affinity for binding activated GEFs, we show that the Rac GEF Vav2 associates with G15ARac1 after VEGF stimulation. Additionally, we show that depleting endothelial cells of endogenous Vav2 with siRNA prevents VEGF-induced Rac1 activation. Moreover, Vav2 is tyrosine phosphorylated upon VEGF treatment, which temporally correlates with Rac1 activation and requires VEGFR-2 signaling and Src kinase activity. Finally, we show that depressing Vav2 expression by siRNA impairs VEGF-induced endothelial cell migration. Taken together, our results provide evidence that Vav2 acts downstream of VEGF to activate Rac1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17686471      PMCID: PMC2034315          DOI: 10.1016/j.yexcr.2007.05.027

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  49 in total

Review 1.  Rho and Rac take center stage.

Authors:  Keith Burridge; Krister Wennerberg
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Neurotrophins regulate Schwann cell migration by activating divergent signaling pathways dependent on Rho GTPases.

Authors:  Junji Yamauchi; Jonah R Chan; Eric M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-25       Impact factor: 11.205

3.  PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase.

Authors:  P T Hawkins; A Eguinoa; R G Qiu; D Stokoe; F T Cooke; R Walters; S Wennström; L Claesson-Welsh; T Evans; M Symons
Journal:  Curr Biol       Date:  1995-04-01       Impact factor: 10.834

Review 4.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

5.  Spatio-temporal regulation of Rac1 and Cdc42 activity during nerve growth factor-induced neurite outgrowth in PC12 cells.

Authors:  Kazuhiro Aoki; Takeshi Nakamura; Michiyuki Matsuda
Journal:  J Biol Chem       Date:  2003-10-21       Impact factor: 5.157

6.  The P2Y2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1).

Authors:  Cheikh I Seye; Ningpu Yu; Fernando A González; Laurie Erb; Gary A Weisman
Journal:  J Biol Chem       Date:  2004-06-02       Impact factor: 5.157

7.  Rac1 function is required for Src-induced transformation. Evidence of a role for Tiam1 and Vav2 in Rac activation by Src.

Authors:  Joan-Marc Servitja; Maria Julia Marinissen; Akrit Sodhi; Xosé R Bustelo; J Silvio Gutkind
Journal:  J Biol Chem       Date:  2003-06-16       Impact factor: 5.157

Review 8.  Vav proteins, masters of the world of cytoskeleton organization.

Authors:  Idit Hornstein; Andres Alcover; Shulamit Katzav
Journal:  Cell Signal       Date:  2004-01       Impact factor: 4.315

9.  Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction.

Authors:  Sara Weis; Satoshi Shintani; Alberto Weber; Rudolf Kirchmair; Malcolm Wood; Adrianna Cravens; Heather McSharry; Atsushi Iwakura; Young-Sup Yoon; Nathan Himes; Deborah Burstein; John Doukas; Richard Soll; Douglas Losordo; David Cheresh
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

10.  Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation.

Authors:  Patrizia Sini; Angela Cannas; Anthony J Koleske; Pier Paolo Di Fiore; Giorgio Scita
Journal:  Nat Cell Biol       Date:  2004-02-22       Impact factor: 28.824

View more
  82 in total

1.  The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularization.

Authors:  Elizabeth Monaghan-Benson; John Hartmann; Aleksandr E Vendrov; Steve Budd; Grace Byfield; Augustus Parker; Faisal Ahmad; Wei Huang; Marschall Runge; Keith Burridge; Nageswara Madamanchi; M Elizabeth Hartnett
Journal:  Am J Pathol       Date:  2010-08-27       Impact factor: 4.307

2.  Vascular endothelial growth factor enhances macrophage clearance of apoptotic cells.

Authors:  Mark T Kearns; Samay Dalal; Sarah A Horstmann; Tiffany R Richens; Takeshi Tanaka; Jenna M Doe; Darren M Boe; Norbert F Voelkel; Laimute Taraseviciene-Stewart; William J Janssen; Chun G Lee; Jack A Elias; Donna Bratton; Rubin M Tuder; Peter M Henson; R William Vandivier
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-03       Impact factor: 5.464

3.  Small Rho GTPase-mediated actin dynamics at endothelial adherens junctions.

Authors:  Jaap D van Buul; Ilse Timmerman
Journal:  Small GTPases       Date:  2016-01-29

4.  Expression of Rac-1 related to tumor depth, lymph node metastasis and patient prognosis in esophageal squamous cell carcinoma.

Authors:  Qing Yang; Guang-Yu Luo; Yin Li; Hong-Bo Shan; Hui-Yun Wang; Guo-Liang Xu
Journal:  Med Oncol       Date:  2013-09-12       Impact factor: 3.064

5.  Active Rac1 improves pathologic VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1.

Authors:  Mien V Hoang; Janice A Nagy; Donald R Senger
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

6.  Regulation of lymphatic-blood vessel separation by endothelial Rac1.

Authors:  Gabriela D'Amico; Dylan T Jones; Emma Nye; Karen Sapienza; Antoine R Ramjuan; Louise E Reynolds; Stephen D Robinson; Vassiliki Kostourou; Dolores Martinez; Deborah Aubyn; Richard Grose; Gareth J Thomas; Bradley Spencer-Dene; Daniel Zicha; Derek Davies; Victor Tybulewicz; Kairbaan M Hodivala-Dilke
Journal:  Development       Date:  2009-12       Impact factor: 6.868

7.  NADPH oxidase in vascular injury: a new insight about its regulation and role in T cells.

Authors:  Jun-ichi Abe; Chang-Hoon Woo
Journal:  Circ Res       Date:  2009-01-30       Impact factor: 17.367

8.  Phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 (P-Rex-1), a guanine nucleotide exchange factor for Rac, mediates angiogenic responses to stromal cell-derived factor-1/chemokine stromal cell derived factor-1 (SDF-1/CXCL-12) linked to Rac activation, endothelial cell migration, and in vitro angiogenesis.

Authors:  Jorge Carretero-Ortega; Colin T Walsh; Ricardo Hernández-García; Guadalupe Reyes-Cruz; Joan Heller Brown; José Vázquez-Prado
Journal:  Mol Pharmacol       Date:  2009-12-17       Impact factor: 4.436

9.  CdGAP regulates cell migration and adhesion dynamics in two-and three-dimensional matrix environments.

Authors:  Duncan Wormer; Nicholas O Deakin; Christopher E Turner
Journal:  Cytoskeleton (Hoboken)       Date:  2012-08-20

10.  Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability.

Authors:  Christopher A Jones; Nyall R London; Haoyu Chen; Kye Won Park; Dominique Sauvaget; Rebecca A Stockton; Joshua D Wythe; Wonhee Suh; Frederic Larrieu-Lahargue; Yoh-Suke Mukouyama; Per Lindblom; Pankaj Seth; Antonio Frias; Naoyuki Nishiya; Mark H Ginsberg; Holger Gerhardt; Kang Zhang; Dean Y Li
Journal:  Nat Med       Date:  2008-03-16       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.